Adenine

Adenine

SCHEMBL2558877

Nc1ncnc2[nH]cnc12.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.50
▸ MAP4K4 O95819 1/20 0.40
▸ PNP P00491 1/20 0.36
▸ PI4KA P42356 2/20 0.33
▸ PI4K2B Q8TCG2 2/20 0.33
▸ PI4K2A Q9BTU6 2/20 0.33
▸ PI4KB Q9UBF8 2/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ XDH P47989 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ABL1 P00519 1/20 0.30
▸ RIN1 Q13671 1/20 0.30
▸ DYRK1A Q13627 1/20 0.30
▸ ERAP1 Q9NZ08 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenine SCHEMBL8469554 0.90 ALDH1A1 (0.43) CRBNMAP4K4PNPPI4KAPI4K2B
Guanine SCHEMBL4577520 0.89 KDM4E (0.43) CRBNMAP4K4PNPLMNAXDH
Adenine SCHEMBL7520981 0.85 CRBN (0.36) CRBNMAP4K4
Guanine SCHEMBL2636585 0.83 KDM4E (0.38) CRBNMAP4K4PNPLMNADYRK1A
Adenine SCHEMBL6227731 0.82 ATAD2 (0.37) CRBNMAP4K4
Adenine SCHEMBL8110 0.79 PI4KA (0.48) MAP4K4PNPPI4KAPI4K2BPI4K2A
Adenine SCHEMBL3416954 0.79 PI4KA (0.48) MAP4K4PNPPI4KAPI4K2BPI4K2A
Adenine SCHEMBL3414603 0.79 PI4KA (0.48) MAP4K4PNPPI4KAPI4K2BPI4K2A
Adenine SCHEMBL3413247 0.79 PI4KA (0.48) MAP4K4PNPPI4KAPI4K2BPI4K2A
Adenine SCHEMBL2558881 0.78 PI4KA (0.63) CRBNPNPPI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1652528-A1 ACTIVATED CARBON INFUSION SOLUTION, PREPARATION METHOD THEREFOR AND USE THEREOF FOR THE MANUFACTURE OF DRUG FOR TREATING CANCER Chen, Xiaochuan (CN) 2006-05-03 — — EP claimed
US-20050123613-A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer CHEN XIAOCHUAN (CN) 2005-06-09 — — US claimed
WO-2011130385-A1 BIOMARKERS FOR HEPATOCELLULAR CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC 2011-10-20 — — WO disclosed
US-20090258794-A1 APOPTOSIS METHODS, GENES AND PROTEINS MORVUS TECHNOLOGY LTD (GB) 2009-10-15 — — US disclosed
EP-1984393-A2 APOPTOSIS METHODS, GENES AND PROTEINS Morvus Technology Ltd. (GB) 2008-10-29 — — EP disclosed
WO-2007093807-A2 APOPTOSIS METHODS, GENES AND PROTEINS MORVUS TECHNOLOGY LIMITED (GB) 2007-08-23 — — WO disclosed
EP-1652528-A1 ACTIVATED CARBON INFUSION SOLUTION, PREPARATION METHOD THEREFOR AND USE THEREOF FOR THE MANUFACTURE OF DRUG FOR TREATING CANCER Chen, Xiaochuan (CN) 2006-05-03 — — EP disclosed
US-20050123613-A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer CHEN XIAOCHUAN (CN) 2005-06-09 — — US disclosed
US-4184271-A Molecular model BARNETT JAMES W JR 1980-01-22 — — US disclosed
Send feedback